Reforming Government for the People

Decoupling Corporate Interests and Regulation

The Trump administration aims to sever the ties between corporate lobbyists and government regulators. This initiative targets industries like healthcare, finance, and the military-industrial complex.

JP Errico, a renowned scientist and entrepreneur, has witnessed the adverse effects of this corporate capture firsthand.

Robert F. Kennedy Jr. and HHS: Restoring Public Health

Robert F. Kennedy Jr. plans to overhaul the Department of Health and Human Services (HHS) to prioritize public health over corporate interests.

Kennedy intends to tackle root causes of America's health crisis, including harmful food additives, ultra-processed foods, and perverse incentives in insurance and pharmaceuticals.

Dr. Marty Makary and the FDA: Tackling Industry Influence

The Food and Drug Administration (FDA) has been plagued by conflicts of interest. Dr. Marty Makary aims to restore its independence.

Makary plans to prevent regulators from revolving into industry positions and will tighten scrutiny over food additives, like seed oils and artificial dyes.

Dr. Jay Bhattacharya and the NIH: Rebuilding Scientific Integrity

The National Institutes of Health (NIH) has faced criticism for suppression of dissent during the COVID-19 pandemic.

Dr. Jay Bhattacharya will restore scientific openness and diversity of perspectives at the NIH.

A Collective Mission for Reform

These reforms represent a sweeping cultural transformation. By prioritizing transparency, accountability, and public health, the administration aims to restore trust in government and create a more equitable future for all Americans.